Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fanin

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Annals of Hematology|September 12, 2002
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemiaD Russo, P P Piccaluga, M Michieli, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 2, 2013
Best practice recommendations in: (1) Peripheral blood stem cell mobilization and collection and (2) acute and chronic GvHD treatment using extracorporeal photopheresis. A joint effort from SIdEM (Società Italiana di Emaferesi e Manipolazione Cellulare) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo)P Perseghin, M Marchetti, C Messina, et al.
Bone Marrow Transplantation|April 29, 2009
Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective studyC Skert, D Damiani, A Michelutti, et al.
Haematologica|January 1, 1994
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomaP L Zinzani, M G Levrero, F Lauria, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 15, 2013
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximabF Patriarca, M Medeot, M Isola, et al.
Mycoses|December 31, 2013
Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo studyA Candoni, M Caira, S Cesaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytomaF Silvestri, G Barillari, R Fanin, et al.
Bone Marrow Transplantation|April 14, 2009
HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor RegistryR Crocchiolo, F Ciceri, K Fleischhauer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantationL Farina, F Barretta, L Scarfò, et al.
Bone Marrow Transplantation|January 17, 2017
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMTG Battipaglia, M Labopin, A Candoni, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Annals of Hematology|September 12, 2002
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemiaD Russo, P P Piccaluga, M Michieli, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 2, 2013
Best practice recommendations in: (1) Peripheral blood stem cell mobilization and collection and (2) acute and chronic GvHD treatment using extracorporeal photopheresis. A joint effort from SIdEM (Società Italiana di Emaferesi e Manipolazione Cellulare) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo)P Perseghin, M Marchetti, C Messina, et al.
Bone Marrow Transplantation|April 29, 2009
Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective studyC Skert, D Damiani, A Michelutti, et al.
Haematologica|January 1, 1994
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomaP L Zinzani, M G Levrero, F Lauria, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 15, 2013
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximabF Patriarca, M Medeot, M Isola, et al.
Mycoses|December 31, 2013
Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo studyA Candoni, M Caira, S Cesaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytomaF Silvestri, G Barillari, R Fanin, et al.
Bone Marrow Transplantation|April 14, 2009
HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor RegistryR Crocchiolo, F Ciceri, K Fleischhauer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantationL Farina, F Barretta, L Scarfò, et al.
Bone Marrow Transplantation|January 17, 2017
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMTG Battipaglia, M Labopin, A Candoni, et al.
Pageof 16